)
Metis TechBio Co (7666) investor relations material
Metis TechBio Co H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved operating revenue of RMB154.3 million for H1 2026, a 13,399% increase year-over-year, driven by major licensing and collaboration agreements.
Adjusted net loss (non-IFRS) reduced by 56.4% to RMB51.1 million, reflecting improved operating efficiency and milestone payments.
Significant progress in AI-driven platforms and expansion of the self-developed pipeline, with multiple candidates advancing in clinical and preclinical stages.
Landmark global licensing deal for MTS-128 with Boulevard Bio, potential value over US$1.6 billion, and new collaborations with BioThunder AG, GenTurn Life, Edibeck, and Hengrui Pharma.
Cash and equivalents, term deposits, and financial assets totaled RMB3,025.3 million, supporting a strong financial position.
Financial highlights
Revenue from contracts with customers rose to RMB154.3 million from RMB1.14 million year-over-year, mainly from collaboration agreements.
Gross profit increased to RMB153.1 million, with gross margin rising to 99.2%.
R&D expenses increased by 48.1% to RMB172.4 million, reflecting continued investment in pipeline and technology.
Administrative expenses rose 70.5% to RMB96.1 million; selling and marketing expenses up 365% to RMB21.3 million.
Loss for the period narrowed by 20% to RMB153.2 million; adjusted net loss (non-IFRS) was RMB51.1 million.
Net current assets reached RMB2,862.5 million; gearing ratio improved to 8.9% from 19.3%.
Cash and cash equivalents: RMB2,527.3 million as of June 30, 2026.
Net cash inflow from financing activities: RMB2,092.7 million, mainly from IPO/Global Offering.
Outlook and guidance
Management expects to meet the revenue requirement for listing rules in 2027, supported by ongoing commercialization and strategic partnerships.
Focus remains on advancing AI-driven life sciences, scaling Biological AI from molecular to cellular level, and expanding global collaborations.
Long-term strategy targets cell reprogramming and end-to-end capabilities from molecular design to cell-fate regulation.
Next Metis TechBio Co earnings date
Next Metis TechBio Co earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)